Anal melanoma in Colombia: A retrospective cohort survival study from an institutional melanoma registry
DOI:
https://doi.org/10.30944/20117582.3224Palabras clave:
anal neoplasms, melanoma, survival analysis, treatment, ColombiaResumen
Introduction. Anal melanoma (AM) is an uncommon and aggressive mucosal melanoma subtype with a poor prognosis. Evidence from Latin America is scarce, and no Colombian study has characterized survival or treatment patterns in AM.
Methods. We performed a retrospective cohort analysis using a national institutional melanoma registry (2010– 2021). From 766 melanoma cases, all patients with histologically confirmed anal or anorectal primary melanoma (ICD-10 C21.x) were included. Clinical, pathological, treatment, and survival data were extracted from electronic medical records. Overall survival (OS) was estimated using Kaplan–Meier analysis.
Results. Seven patients (0.9%) had AM. The median age at diagnosis was 61 years; 71.4% were female, most belonged to low socioeconomic strata. Diagnostic delay was frequent: median symptom-to-diagnosis interval was 7 months. At presentation, 71.4% had distant metastases; ulceration was present in 85.7%. Treatments included wide/local excision (42.8%), abdominoperineal resection (28.6%), radiotherapy (57.1%), and systemic therapy (71.4%), including immune checkpoint inhibitors. Toxicities led to treatment discontinuation in some cases. Median OS: 9.4 months; patients diagnosed with metastatic disease had an OS of 4.2 months. Six patients died despite multimodal therapy. The only 5-year survivor was diagnosed incidentally at an early stage.
Conclusion. Anal melanoma in Colombia is rare but almost uniformly fatal. Delayed diagnosis—due to nonspecific anorectal symptoms and limited access to specialist evaluation—was the dominant driver of poor survival. Early detection, particularly in patients with a personal history of melanoma, is crucial. Prompt anorectal examination and biopsy of persistent symptoms may offer the only opportunity to alter prognosis.
Descargas
Referencias bibliográficas
Huang H, Chen L, Chen T, Sun G. Rectal malignant melanoma: a case report and literature review. World J Surg Oncol. 2025;23:17. https://doi.org/10.1186/s1295702503632-8
García AM, ParraLara LG, MendozaUrbano DM, Bravo JC, Zambrano Harvey Á. Survival of patients with mucosal melanoma in Cali, Colombia: a retrospective cohort study. BMC Cancer. 2024;24:886. https://doi.org/10.1186/s12885024131707
Jutten E, Kruijff S, Francken AB, Lutke Holzik MF, van Leeuwen BL, van Westreenen HL, et al. Surgical treatment of anorectal melanoma: a systematic review. Updates Surg. 2021;73:1407-17. https://doi.org/10.1093/bjsopen/zrab107
Shan Z, Liu F. Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes. Front Immunol. 2024;15:1441410. https://doi.org/10.3389/fimmu.2024.1441410
Arias Flórez M, Moreno Gómez GA, Aguirre Flórez M, López Bueno I, Moreno Gómez J, Moreno Gómez M, et al. Melanoma in a Colombian population: a survival study. Melanoma Manag. 2024;11:2382079. https://doi.org/10.2217/mmt20240003
Paolino G, Podo Brunetti A, De Rosa C, Cantisani C, Rongioletti F, Carugno A, et al. Anorectal melanoma: systematic review of the current literature. Dermatol Ther (Heidelb). 2024;14:1667-84. https://doi.org/10.1007/s13555024010791
Chen H, Cai Y, Liu Y, He J, Hu Y, Xiao Q, et al. Incidence, surgical treatment, and prognosis of anorectal melanoma. Medicine (Baltimore). 2016;95:e2770. https://doi.org/10.1097/MD.0000000000002770
Liu C, Tang C, Zhang J, Zhu P. Extensive resection improves overall and disease-specific survival compared with local excision in localized anorectal melanoma: a SEER-based analysis. Front Surg. 2022;9:997169. https://doi.org/10.3389/fsurg.2022.997169
Ortega A, GarcíaMarín A, Alós R, et al. Melanoma anorrectal: actualización. Cir Esp. 2015;93:e73e82. https://doi.org/10.1016/j.ciresp.2015.04.009
Biswas J, Matthews S, Gopal L, et al. Challenges in managing anorectal melanoma. Clin Imaging. 2023;92:73-82. https://doi.org/10.1016/j.clinimag.2022.11.020
Ghiasvand R, Robsahm TE, Green AC, Veierød MB. Incidence and factors associated with second primary invasive melanoma. JAMA Dermatol. 2024;160:402-8. https://doi.org/10.1001/jamadermatol.2023.6251
Du Y, Wang X, Mao X, Cai B, Peng J, Li H, et al. Immunotherapy for mucosal melanoma. Oncol Transl Med. 2023;9:179-88. https://doi.org/10.1097/OT9.0000000000000019
ASCO Daily News. Management of anorectal melanoma in an era of immunotherapy. ASCO Daily News. Jan 6, 2021. Available from: https://dailynews.ascopubs.org/do/management-anorectal-melanoma-era-immunotherapy.
Wallington DG, Fernandez J, Perkins S, et al. Complete and durable response after radiation therapy combined with checkpoint blockade in mucosal melanoma. Adv Radiat Oncol. 2020;5:1174-9. https://doi.org/10.1016/j.adro.2020.08.002
Marulanda Fernández H, Velásquez D, RíosBermúdez A, GarcíaMoreno M, Cadena M, Restrepo CC, et al. Primary anorectal melanoma: case report and literature review. Rev Col Gastroenterol. 2023;38:e1357. https://doi.org/10.22516/25007440.1357
NiY, Chen S, Wang S, LiP, ZhangY, HuangX, et al. Absolute risk of developing a second primary cancer after a first melanoma. Am J Epidemiol. 2025;kwaf068. https://doi.org/10.1093/aje/kwaf068
Antoñanzas J, García-Fernández S, MartínezCuadrado G, Pérez-Gómez B, Sánchez-Sánchez R, LópezLópez J, et al. Risk of second primary malignancies in melanoma survivors: a populationbased study. Cancers (Basel). 2023;15:3056. https://doi.org/10.3390/cancers15113056
Edelman A, Brown T, Gandhi R, Gandhi R. Anorectal melanoma misdiagnosed as hemorrhoids: a case report. Cureus. 2021;13:e15055. https://doi.org/10.7759/cureus.15055
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Revista Colombiana de Cirugía

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Todos los textos incluidos en la Revista Colombiana de Cirugía están protegidos por derechos de autor. Las opiniones expresadas en los artículos firmados son las de los autores y no coinciden necesariamente con las de los directores o los editores de la Revista Colombiana de Cirugía. Las sugerencias diagnósticas o terapéuticas como elección de productos, dosificación y métodos de empleo corresponden a la experiencia y al criterio de los autores.
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | 310 |
| Vistas de PDF | 99 |
| Descargas de PDF | 99 |
| Vistas de HTML | 0 |
| Otras vistas | 0 |












.jpg)

